Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Accuray ( (ARAY) ) has provided an update.
On January 21, 2025, Accuray Incorporated announced the appointment of Leonel Peralta as Senior Vice President and Chief Operations Officer, effective February 3, 2025. Peralta, with over 25 years of leadership experience in supply chain and manufacturing optimization, most recently served at Siemens Healthineers and has held positions at Medtronic Diabetes, Hill-Rom (Baxter), KCI Medical (3M), and GE Healthcare. His extensive expertise is expected to enhance Accuray’s global operations and drive business growth, particularly as the company expands its radiation therapy system portfolio.
More about Accuray
Accuray is a company committed to enhancing the potential of radiation therapy to improve lives through innovation. It develops market-changing solutions for delivering radiation treatments for complex and common cases, aiming to meet a wide range of patient needs. Accuray focuses on continuous innovation in radiation therapy, oncology, and neuro-radiosurgery, and partners with clinicians and administrators to empower faster patient recovery. The company is headquartered in Sunnyvale, California, with facilities worldwide.
YTD Price Performance: 14.87%
Average Trading Volume: 660,896
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $225.3M
See more data about ARAY stock on TipRanks’ Stock Analysis page.
